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1. Introduction
  There is no obvious symptom at early onset of chronic 
kidney disease, which is known as “invisible killer”. It 
has seriously damage to human body health[1-3]. End-
stage renal failure is the advanced stage of chronic kidney 
disease. Once patients with chronic renal failure were 
in end-stage of renal failure, they can only be treated 
with lifelong dialysis or renal transplantation with poor 
prognosis. It brings serious burden to patients and their 
family[4]. Glomerular sclerosis and renal interstitial fibrosis 
are the foundation of chronic renal disease. When it occurs, 
damaged kidney tissues will start to repair itself. The 
process is mainly characterized by extracellular matrix 
deposition and a large number of inflammatory cells 
infiltration. Accumulation of excessive extracellular matrix 
can cause scar formation and structure reconstruction of 
kidney fibrous, which will lead to renal parenchyma and 
renal damage[5-8]. Studies have shown that[9], in patients 
with chronic kidney disease, kidney damage and renal 
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interstitial involvement levels are positively correlated, 
and renal interstitial fibrosis plays a decisive role. It is the 
main pathological basis of chronic renal failure. Therefore, 
correction of renal damage at early stage can delay the 
progress of chronic kidney disease. Its clinical research has 
become a hot spot.
  Pathogenesis of renal damage is not fully clear. Studies 
have shown that[9-11], transforming growth factor 毬1 - 
(TGF - 毬1) and connective tissue growth factor (CTGF) will 
play important roles in the occurrence and development 
of renal interstitial injury and chronic kidney disease. To 
study the effect of alprostadil combined with diammonium 
glycyrrhizinate on the renal interstitial fibrosis, we 
established unilateral ureteral obstruction model in  SD rats, 
and treat rats with alprostadil combined with diammonium 
glycyrrhizinate intervention. Then we observed interstitial 
expression changes and its concentration of TGF - 毬1 and 
CTGF before and after treatment, to provide experimental 
basis for prevention and control of renal interstitial fibrosis.
 
2. Materials and methods
2.1. Experimental animals  
  A total of 75 healthy male SD rats, weighting 180-190 g, 
provided by the Laboratory Animal Center were selected, 
They were provided with class II feeding with free access 
to water and food. After 4 days of breeding, models were 
established. It followed the related provisions of the 
Regulations on of Experimental Animals.
2.2.  Instrument and reagent
  DXC800 automatic biochemistry analyzer (BECKMAN 
Company, USA); Automatic dewaterer (LEICA Company, 
Germany); Low temperature high speed centrifuge, 
optical microscope (OLYMPUS Company, Japan). 10% 
chloral hydrate, provided by the National Medicine Group 
Chemical Reagent Beijing Co., LTD.; alprostadil (Beijing Ted 
Pharmaceutical Co., LTD., production, specifications: 10 毺g/
kit); diammonium glycyrrhizinate injection (Jiangsu Zhengda 
Pharmaceutical Co., LTD. specifications 50 mg/kit); TGF-毬
1 single antibody, Goat anti Human CTGF IgG, CTGF ELISA 
kit and TGF-毬1 ELISA kit were from ShangBai Biomedical 
Technology Co., LTD. Goat anti Rabbit IgG, SP kits, pig anti 
sheep IgG were from Huamei Biological Engineering Co., 
LTD.
2.3. Model establishment
  Rats were intraperitoneal injected with ketamine 
anesthesia (120 mg/kg), and fixed on right side. They were 
sheared, regular disinfected and received abdomen midline 
incision. They were cut step by step, layers of tissue were 
separated. After the bladder was exposed, the left ureter 
was separated, the lower ureteral ducts were ligated with a 
5-0 ligation thread, with the upper point at the end of left 
kidney. Ureteral duct was clipped between ligation points, 
then incisions were sew.
2.4. Grouping
  A total of 75 SD rats were randomly divided into A, B, 
C, D, E groups with 15 in each group. Group A served as 
the control group, rats had only tissue separation without 
modeling operation; while model of unilateral ureteral 
obstruction (UUO) was established in B, C, D, E group. As the 
model group, rats in group B were only given comfort saline 
10 mL lavage placebo treatment after modeling. Rats in C, 
D, E group were given diammonium glycyrrhizinate 20 mg/
kg-1.d-1, alprostadil 4 毺g/kg
-1.d-1 and combination injection 
therapy of diammonium glycyrrhizinate and alprostadil 
4毺g/kg
-1.d-1  with same dose as above.  
2.5. Serum concentration of TGF -毬1, CREA 
  Five rats were sacrificed 1, 2, 3 weeks after modeling, 
serum creatinine level of femoral venous blood were 
determined. TGF-毬1 and concentration of connective 
tissue growth factor (CTGF) were detected by using ELISA.
2.6. Histological observation
  After the completion of blood extraction, the left kidney 
was immediately extracted. It was avaged with warm saline. 
After fat capsule and renal capsule stripping, about 3 mm3 
kidney tissues were taken along the long axis of kidney. 
They were fixed in 10% formaldehyde, received conventional 
dehydration. Then they had paraffin embedding after 24 h, 
4 毺m tissue section was prepared for HE stain. Expression 
of TGF -毬 1, CREA in renal tissue were observed under 
microscope. Dyeing method was as follows: they had 
dewaxing hydration, then were washed by PBS three times, 
added with 3% H2O2 for 10 min, washed by PBS three times. 
They were heated by microwave for 10 min, added with goat 
serum for 20 min, and 1:100 rabbit anti human TGF-毬1 
(primary antibodies), then placed for 1 h at 37 曟, washed 
by PBS three times. They were added with 1:60 goat anti 
rabbit (second antibody), placed for 1 h at 37 曟, washed by 
PBS three times. They were added with SP reagent for 30 
min at room temperature, washed with PBS, DAB stained 
and had hematoxylin redyeing, followed by dehydration, 
transparentation, sealing and then were observed under 
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microscopy. CTGF was determined by immunohistochemical 
SP method. 
2.7. Statistical analysis
  Processed data were analyzed by using SPSS 16.0 software, 
One-Way ANOVA was used for data comparison among 
groups (mean依sd), P<0.05 was regarded as statistically 
significant difference.
3. Results 
3.1. Compression of serum creatinine levels
  Serum creatinine levels of B, C, D, E group at different time 
points were significantly higher than that of group A (P<0.05); 
serum creatinine levels of group B were significantly higher 
than those of C, D, E group at each time point (P<0.05); 
serum creatinine level of group E was significantly lower 
than those of C, D group after 2, 3 weeks (P<0.05), as shown 
in Table 1.
3.2. TGF -毬1 and CREA concentration in serum at each 
time point 
  Rats in group A at each time point showed no significant 
changes in TGF -毬1 and CREA concentration of serum 
(P>0.05); in B, C, D, E groups serum TGF -毬1, concentration 
of CREA, expression showed a gradual increasing trend 
over time; TGF -毬1 and CREF of group B in serum at each 
time point were significantly higher than that of the other 
groups (P<0.05); TGF -毬1 and CREF of group E in serum at 
each time point were significantly lower than that of  B, C, D 
group at all time points in serum (P<0.05), as shown in Table 
2.
3.3. Histological observation
  Group A showed no or mild expression of TGF-毬1 in renal 
interstitial tissue, in group B there were large expressions 
in renal interstitial tissue with increasing trend over time, 
and both expressions were positively correlated. Expression 
of TGF-毬1 and CREF in renal interstitial tissue of C, 
D, E group were significantly lower than that of group B, 
expression of TGF-毬1 and CREF renal interstitial tissue of 
group E was significantly lower than that of group C and D 
(Figure 1, 2).
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Figure 1.  Expression of TGF-毬1 in renal interstitial tissues in group 
B and E at each time point (×200).
Table 1
 Compression of serum creatinine levels  (毺mol/L, n=5)
Groups 1 week after modeling 2 weeks after modeling 3 weeks after modeling
A group 56.22依0.32 56.17依0.32 56.20依0.26
B group 61.03依1.13*  82.22依1.29* 139.88依1.08*
C group 58. 58依1.27*#      77.72依0.70*#△     127.30依1.03*#△
D group 56.96依0.62*#      73.08依0.34*#△     117.82依1.19*#△
E group 56.76依0.42*#   66.75依0.94*#    90.72依0.72*#
Compared with group A*P<0.05; Compared with group B#P<0.05; Compared with group E△P<0.05.
Table 2
TGF -毬1 and CREA concentration in serum at each time point.
Groups
TGF-毬1(ng/ mL) CREA(pg/mL)
1 week after modeling 2 weeks after modeling 3 weeks after modeling 1 week after modeling 2 weeks after modeling 3 weeks after modeling
A group 33.06依0.48 32.85依0.15   32.93依0.54 104.87依0.35 105.30依0.32 104.97依0.22
B group  62.30依2.65* 104.40依3.30*  142.24依8.02*  147.22依5.62*  183.92依4.70*  366.40依3.69*
C group      51.20依2.69*#△       94.07依3.28*#△      117.51依5.12*#△      129.93依2.26*#△      144.25依3.90*#△      246.26依4.46*#△
D group      48.18依2.42*#△       84.40依2.27*#△      106.90依3.54*#△      135.02依3.70*#△      156.75依2.67*#△      284.13依4.82*#△
E group   42.09依1.83*#    71.61依2.44*#     90.17依2.37*#   114.55依3.29*#   125.80依4.15*#     185.00依4.07*#
Compared with group A*P<0.05; Compared with group B#P<0.05; Compared with group E △P<0.05.
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Figure 2. Expression of CREA in renal interstitial tissues in group B 
and E at each time point (×200).
3.4. TGF -毬1 and CREA concentration in tissues at each 
time point 
  Group A of rats at each time point showed no significant 
changes IN TGF -毬1 and CREA concentration OF 
tissues (P>0.05); B, C, D, E groups of rats tissues TGF -
毬1, concentration of CREA, expression showed gradual 
increasing trend over time; TGF -毬1 and CREF of Group 
B in tissues at each time point were significantly higher 
than that of the other groups (P<0.05); TGF -毬1 and CREF 
of Group E in tissues at each time point were significantly 
lower than that of  B, C, D group at all time points in tissues 
(P<0.05), as shown in Table 3.
4. Discussion
  Renal interstitial fibrosis happens when repairing damage 
process is out of control[12]. Renal interstitial fibrosis 
process may promote/suppress fibrosis cytokine imbalance, 
oxidative stress, inflammation, etc[13]. Renal interstitial 
fibrosis is common pathway related to a variety of chronic 
progressive kidney diseases, progressive development is the 
main pathological basis of kidney failure, and the degree 
of renal interstitial fibrosis also plays a leading role in the 
in kidney disease outcome[14-18]. Therefore, the study on 
renal interstitial fibrosis is of great significance to to delay 
the progress of chronic kidney disease and improve the 
prognosis of patients.
  Renal interstitial fibrosis pathogenesis is not fully clear. 
Studies have confirmed that[19-22], serum creatinine level 
and the degree of renal interstitial injury were positively 
correlated. In this study, serum creatinine levels of B, C, D, 
E group at different time points were significantly higher 
than that of group A, and serum creatinine level of group 
E was significantly lower than C, D group after 2, 3 weeks 
of modeling (P<0.05), suggesting alprostadil combined with 
diammonium glycyrrhizinate can improve renal interstitial 
fibrosis of the rat kidney function, increase the serum 
creatinine clearance. Other studies reported the TGF-
毬1 and CREA are the basis of renal interstitial fibrosis 
disease, play an important role in the onset process[23-25]. 
Therefore, how to inhibit the effect of two kinds of cytokines 
have become the important way for the treatment of renal 
interstitial fibrosis. TGF-毬1 is recognized as the strongest 
fibrosis induced factor. It can induce renal tubular epithelial 
cells apoptosis, thus promote renal interstitial ECM protein 
deposition, and cause renal interstitial fibrosis. Studies have 
shown that[19], glycyrrhizic acid can inhibit the synthesis 
effectsof prostaglandin E2 direct on cell membrane, 
playing the role like glucocorticoid, then to realize the anti 
fibrosis and to suppress the immune function. In addition, 
glycyrrhizic acid can inhibit the activity of mesenchymal 
cells, thus reduce the secretion of TGF-毬1. In this study, 
renal interstitial TGF-毬1 expression and concentration 
in serum of group E was significantly lower than that of B, 
C, D group (P<0.05), suggesting alprostadil combined with 
diammonium glycyrrhizinate can significantly inhibit renal 
interstitial fibrosis in the rat TGF-毬1, CREA expression, 
so as to delay the process of renal interstitial fibrosis. This 
study showed that, Group A showed no or mild expression of 
TGF-毬1 in renal interstitial tissue. In group B there were 
large expressions in renal interstitial tissue with increasing 
trend over time, and both expressions were positively 
correlated. Expression rates of TGF-毬1 and CREF renal 
interstitial tissue of C, D, E group were significantly lower 
than that of group B, expression rate of TGF-毬1 and CREF 
renal interstitial tissue of group E was significantly lower 
Table 3
TGF -毬1 and CREA concentration in tissues at each time point (%,n=5).
Groups
TGF-毬1 CREA
1 week after modeling 2 weeks after modeling 3 weeks after modeling 1 week after modeling 2 weeks after modeling 3 weeks after modeling
A group  3.05依0.12  3.06依0.09  3.06依0.10 0.97依0.18 0.98依0.16  0.97依0.24
B group 11.03依0.24* 16.47依0.48* 34.88依0.59*  3.27依0.42*  7.00依0.45* 14.73依0.75*
C group       7.63依0.46*#△     12.90依0.50*#△     22.31依0.75*#△      1.96依0.13*#△      4.04依0.34*#△       9.06依0.63*#△
D group       8.83依0.44*#△     13.95依0.13*#△    28.94依1.48*#△      2.75依0.30*#△      5.75依0.32*#△     11.30依0.62*#△
E group    5.73依0.52*#    9.70依0.66*# 15.31依0.75*#   1.50依0.22*#   3.54依0.38*#     6.55依0.47*#
Compared with group A*P<0.05; Compared with group B#P<0.05; Compared with groupE △P<0.05.
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than that of group C and D, suggesting that alprostadil 
combined with diammonium glycyrrhizinate can effectively 
alleviate the renal fibrosis, improve renal function. Their 
synergy mechanism may be related to downgrading of TGF-
毬1 and CTGF in the renal interstitial expression.
  Alprostadil combined with diammonium glycyrrhizinate 
can significantly lower the expression of TGF -毬1 and 
CTGF in serum and tissues of SD rat with renal interstitial 
fibrosis, thus inhibit rat renal interstitial fibrosis process. 
They have synergy protective effect on renal interstitial 
fibrosis in SD rats.
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